文献速递脑血管病

病前残疾患者卒中后状态恶化带来的长期后果

Long-Term Consequences of Worsened Poststroke Status in Patients With Premorbid Disability.
PubMed 文献 · Stroke · 2018-01-01

在基于人群的前瞻性队列OXVASC(2002-2014)中,1607例缺血性卒中患者有530例(33.0%)病前改良Rankin量表(mRS)评分为2至4分,其中仅2例接受溶栓治疗,421例(79.4%)在3个月时存活。校正年龄、性别和初始美国国立卫生研究院卒中量表评分后,卒中后3个月mRS较病前的变化程度(ΔmRS)与5年死亡/机构化及5年医疗/社会照护费用独立相关。

要点

  • 病前mRS 2至4分的缺血性卒中患者中,仅2例接受溶栓治疗。
  • ΔmRS与5年死亡/机构化独立相关,ΔmRS=1、2、3的校正风险比分别为1.59、2.39、4.12。
  • ΔmRS≥2较ΔmRS=0的5年医疗/社会照护费用边际差为30 011美元。

核心结论

  • 病前残疾的卒中患者若因卒中而累积额外残疾,其死亡、机构化和费用均更高。
  • 这些发现突显了若对轻中度病前残疾患者常规不给予急性干预,预期的长期结局。
  • 作者建议试验/登记研究应纳入此类患者。

研究设计与样本

  • 基于人群的前瞻性队列OXVASC(牛津血管研究,2002-2014),纳入缺血性卒中患者。
  • 在随访期间追踪死亡、机构化和医疗/社会照护费用。
  • 分析对象为病前mRS 2至4分(排除极重度残疾mRS=5)且卒中后3个月存活的患者,共530例。
  • 采用Cox回归比较5年死亡和卒中后机构化,采用广义线性模型比较5年医疗/社会照护费用,并校正年龄、性别和初始美国国立卫生研究院卒中量表评分。

主要发现

  • 1607例患者中530例(33.0%)病前mRS为2至4分。
  • 病前残疾患者中仅2例接受溶栓治疗,421例(79.4%)在3个月时存活。
  • ΔmRS与5年死亡/机构化独立相关:ΔmRS=1 vs 0的校正风险比为1.59(95%CI 1.20-2.11),ΔmRS=2为2.39(95%CI 1.62-3.53),ΔmRS=3为4.12(95%CI 1.98-8.60),P<0.001。
  • ΔmRS≥2 vs 0的5年医疗/社会照护费用边际差为30 011美元(95%CI 4222-55 801美元),P=0.023。
  • 分别分析病前mRS 2、3、4分患者结果相似,例如病前mRS=3且ΔmRS=1 vs 0的5年死亡/机构化校正风险比为1.60(95%CI 1.06-2.42),P=0.027;ΔmRS=2为3.20(95%CI 1.85-5.54),P<0.001。

临床怎么用

  • 作者认为试验/登记研究应纳入病前轻中度残疾的卒中患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Patients with premorbid disability, generally defined as modified Rankin Scale (mRS) score ≥2, are often excluded from trials of acute stroke therapies. However, increased disability in such patients will adversely affect long-term outcomes if treatments are withheld in routine practice. We assessed the extent to which increased disability poststroke influences 5-year mortality, institutionalization, and costs in premorbidly disabled patients. Methods- In a population-based, prospective cohort of patients with ischemic stroke (OXVASC [Oxford Vascular Study], 2002-2014), we tracked mortality, institutionalization, and healthcare/social-care costs during follow-up. We compared 5-year mortality and poststroke institutionalization (Cox regressions) and 5-year healthcare/social-care costs (generalized linear model) in 3-month survivors with premorbid mRS of 2 to 4 (excluding extreme disability, mRS=5), based on the degree of change in mRS(ΔmRS) from prestroke to 3 months poststroke, adjusting analyses for age/sex/initial National Institutes of Health Stroke Scale. Results- Among 1607 patients, 530 (33.0%) had premorbid mRS of 2 to 4. Only 2 premorbidly disabled patients received thrombolysis, but 421 (79.4%) were alive at 3 months. ΔmRS was independently associated with 5-year mortality/institutionalization (adjusted hazard ratio for ΔmRS=1 versus 0: 1.59; 95% CI, 1.20-2.11; ΔmRS=2: 2.39; 95% CI, 1.62-3.53; ΔmRS=3: 4.12; 95% CI, 1.98-8.60; P<0.001) and costs (margin for ΔmRS ≥2 versus 0: $30 011, 95% CI, $4222-55 801; P=0.023). Results were similar on examining patients with premorbid mRS of 2, 3, and 4 separately (eg, 5-year mortality/institutionalization adjusted hazard ratio for premorbid mRS=3 with ΔmRS=1 versus 0: 1.60; 95% CI, 1.06-2.42; P=0.027; ΔmRS=2: 3.20; 95% CI, 1.85-5.54; P<0.001). Conclusions- Patients with stroke with premorbid disability have higher mortality, institutionalization, and costs if they accumulate additional disability because of the stroke. These findings highlight the long-term outcomes expected if acute interventions are routinely withheld in patients with mild-moderate premorbid disability and suggest that trials/registries should include such patients.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Ganesh A, Luengo-Fernandez R, Pendlebury ST, et al. Long-Term Consequences of Worsened Poststroke Status in Patients With Premorbid Disability. Stroke. 2018. PMID: 30355105. doi:10.1161/STROKEAHA.118.022416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。